Voya Investment Management LLC Increases Stock Holdings in Bath & Body Works, Inc. $BBWI

Key Points

• Voya Investment Management LLC increased its stake in Bath & Body Works by 180.5% during the 1st quarter, owning over 110,000 shares worth approximately $3.35 million.
• Bath & Body Works reported EPS of $0.37 for its latest quarter, matching analysts' expectations, while its revenue decreased by 0.8% year-over-year.
• The company declared a quarterly dividend of $0.20, resulting in an annualized yield of 3.2% and a payout ratio of 23.74%.

Voya Investment Management LLC boosted its position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 180.5% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 110,405 shares of the company's stock after purchasing an additional 71,051 shares during the period. Voya Investment Management LLC owned about 0.05% of Bath & Body Works worth $3,347,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of BBWI. SVB Wealth LLC purchased a new position in Bath & Body Works in the first quarter worth about $35,000. Geneos Wealth Management Inc. lifted its position in shares of Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company's stock valued at $35,000 after buying an additional 801 shares in the last quarter. Golden State Wealth Management LLC lifted its position in shares of Bath & Body Works by 94.7% during the 1st quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock valued at $40,000 after buying an additional 642 shares in the last quarter. UMB Bank n.a. lifted its position in shares of Bath & Body Works by 65.9% during the 1st quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock valued at $46,000 after buying an additional 596 shares in the last quarter. Finally, GKV Capital Management Co. Inc. purchased a new position in shares of Bath & Body Works during the 1st quarter valued at about $69,000. 95.14% of the stock is owned by hedge funds and other institutional investors.

Bath & Body Works Price Performance

NYSE:BBWI opened at $25.11 on Friday. Bath & Body Works, Inc. has a 1 year low of $24.93 and a 1 year high of $41.87. The stock's 50 day simple moving average is $29.58 and its two-hundred day simple moving average is $29.80. The company has a market cap of $5.18 billion, a price-to-earnings ratio of 7.45, a PEG ratio of 0.90 and a beta of 1.49.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings data on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.37. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The business had revenue of $1.55 billion for the quarter, compared to the consensus estimate of $1.55 billion. During the same quarter in the previous year, the company posted $0.37 EPS. The company's revenue was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, analysts anticipate that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 5th. Shareholders of record on Friday, August 22nd were paid a $0.20 dividend. The ex-dividend date of this dividend was Friday, August 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 3.2%. Bath & Body Works's payout ratio is presently 23.74%.

Analysts Set New Price Targets

BBWI has been the topic of a number of analyst reports. JPMorgan Chase & Co. lifted their price objective on Bath & Body Works from $40.00 to $46.00 and gave the company an "overweight" rating in a research report on Monday, July 28th. Citigroup lowered their price objective on Bath & Body Works from $42.00 to $40.00 and set a "buy" rating on the stock in a research report on Tuesday, August 19th. Morgan Stanley lowered their price objective on Bath & Body Works from $19.00 to $18.00 and set an "overweight" rating on the stock in a research report on Friday, September 12th. Telsey Advisory Group reaffirmed an "outperform" rating and set a $38.00 price objective on shares of Bath & Body Works in a research report on Thursday, August 28th. Finally, Wall Street Zen cut Bath & Body Works from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Twelve equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $39.69.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.